• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Crit Care . Emerging SARS-CoV-2 variants of concern and potential intervention approaches

tetano

Editor, Senior Moderator
Crit Care


. 2021 Jul 12;25(1):244.
doi: 10.1186/s13054-021-03662-x.
Emerging SARS-CoV-2 variants of concern and potential intervention approaches


Jasmin Khateeb[SUP] 1 2 [/SUP], Yuchong Li[SUP] 1 3 [/SUP], Haibo Zhang[SUP] 4 5 6 [/SUP]



Affiliations

Abstract

The major variant of concerns (VOCs) have shared mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike proteins, mostly on the S1 unit and resulted in higher transmissibility rate and affect viral virulence and clinical outcome. The spike protein mutations and other non-structural protein mutations in the VOCs may lead to escape approved vaccinations in certain extend. We will discuss these VOC mutations and discuss the need for combination therapeutic strategies targeting viral cycle and immune host responses.

Keywords: B.1.1.7; B.1.351; P.1. B.1617.1; Transmissibility; Viral virulence.
 
Back
Top Bottom